SABS icon

SAB Biotherapeutics
SABS

Overview Fund Activity

26 hedge funds and large institutions have $65.9M invested in SAB Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
Basso Capital Management
Connecticut
$6.74M
2
PC
2
Periscope Capital
Ontario, Canada
$5.89M
3
KIM
3
Karpus Investment Management
New York
$5.84M
4
SCM
4
Shaolin Capital Management
Florida
$5.11M
5
MP
5
Mangrove Partners
Connecticut
$5.09M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$1K +$1K +13 New
1
2